Clinical trial NCT05710796: AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS
Official title: AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Gender Discrimination
Cardiac Event
Complication
Keywords: Cardiovascular involvement
COVID 19 disease
Gender difference
Lead sponsor: Kakatiya University
Sponsor class: OTHER
First posted: 2023-02-02
Enrollment: 500
Sex: ALL
Minimum age (years): 18
Maximum age (years): 100
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patient reporting to the cardiology department during study period

Brief summary: Aim of the study is to evaluate the prevalence and bring awareness ofcardiovascular complications in COVID-19 recovered patients. Study is conducted at single site, which is Srinivasa Heart Centre, Warangal, Telangana state in India for the duration of 4 months. The sample size is calculated 500 patients and the study is cohort, observational study. Patient consent has been taken before enrolment.

Detailed description: The aim of the study is to evaluate the prevalence and bring awareness of cardiovascular complications in COVID-19 recovered patients.

Objectives of the study:

1. To study causes and risk factors of cardiac disorders associated with COVID-19
2. To identify different types of cardiac symptoms patients, present with
3. To study the impact of co-morbidities on COVID-19 recovered patients
4. To study treatment patterns and duration of therapy

Plan to study:

* To select the patient based on inclusion and exclusion criteria
* To collect the patient information from case sheets and by patient interaction
* To identify different types of cardiac disorders related to COVID-19 or its treatment regimen
* To study the management of COVID-19 complication and related cardiovascular disorders

Study Sites: Srinivasa Heart Centre, Warangal (T.S) Study Design: Observational cohort study Study Duration: 4 months

Subject Eligibility:

1. Inclusion Criteria

   * Patients who are willing to participate
   * Patients having previous COVID-19 treatment record
   * Prescriptions reported during the study period
   * The prescription which is legible and complete
2. Exclusion Criteria

   * Patients who are not willing to participate
   * The patient having no history of COVID-19 and available data

Source of the data:

1. Review of patient case sheet, prescription and lab reports
2. Personal interaction with patients and caregivers

Sample size: 500 Patients

Eligibility criteria: Inclusion Criteria:

* Patients who are willing to participate
* Patients having previous COVID-19 treatment record
* Prescriptions reported during the study period
* The prescription which is legible and complete

Exclusion Criteria:

* Patients who are not willing to participate
* The patient having no history of COVID-19 and available data

Primary outcomes:
measure: ECG, Lipid profile, TMT, and 2D Echo
timeFrame: September 2021 to February 2022
Secondary outcomes:
Other outcomes:
Locations:
city: Warangal
country: India
facility: Srinivasa Heart Centre
state: Telangana
Study officials:
References: